E1	Condition:T1 Name:T2
E3	Observation:T3 Name:T4 Duration:E10
E6	Condition:T6 
E7	Eq-Comparison:T19 Operator:T11 Value:T14 Value2:T15 Temporal-Unit:T9
E8	Eq-Comparison:T20 Operator:T12 Value:T17 Value2:T18 Unit:T35 Per:T36
E2	Drug:T21 Name:T22
E4	Drug:T23 Name:T24
E9	Negation:T26 Negates:E4
E10	Eq-Comparison:T27 Operator:T28 Value:T13 Temporal-Unit:T8
E11	Drug:T29 Name:T30
E12	Drug:T31 Name:T32 Temporality:E7 Duration:E13 Temporality2:E8
E13	Eq-Comparison:T33 Operator:T34 Value:T16 Temporal-Unit:T10
E14	Drug:T37 Name:T38
E15	Study:T39 
E18	Observation:T41 Name:T5
E17	Negation:T43 Negates:E1
E19	Observation:T44 Name:T45
E20	Observation:T46 Name:T47
E21	Drug:T48 Name:T49
E22	Drug:T50 Name:T51
E24	Modifier:T53 Modifies:E6
E25	Modifier:T54 Modifies:E6
T1	Condition 503 525	cardiovascular disease
T2	Condition-Name 503 525	cardiovascular disease
T3	Observation 130 147	strength training
T4	Observation-Name 130 147	strength training
T6	Condition 668 675	disease
T7	Condition-Name 668 675	disease
T8	Eq-Temporal-Unit 163 168	years
T9	Eq-Temporal-Unit 308 313	weeks
T10	Eq-Temporal-Unit 329 334	years
T11	Eq-Operator 302 304	to
T12	Eq-Operator 341 342	-
T13	Eq-Value 161 162	2
T14	Eq-Value 300 301	8
T15	Eq-Value 305 307	12
T16	Eq-Value 327 328	2
T17	Eq-Value 340 341	2
T18	Eq-Value 342 343	4
T19	Eq-Comparison 300 313	8 to 12 weeks
T20	Eq-Comparison 340 359	2-4 cycles per year
T21	Drug 25 53	Anabolic androgenic steroids
T22	Drug-Name 25 53	Anabolic androgenic steroids
T23	Drug 64 92	Anabolic androgenic steroids
T24	Drug-Name 64 92	Anabolic androgenic steroids
T26	Negation 93 101	nonusers
T27	Eq-Comparison 152 168	at least 2 years
T28	Eq-Operator 152 160	at least
T29	Drug 175 203	Anabolic androgenic steroids
T30	Drug-Name 175 203	Anabolic androgenic steroids
T31	Drug 239 267	anabolic androgenic steroids
T32	Drug-Name 239 267	anabolic androgenic steroids
T33	Eq-Comparison 318 334	at least 2 years
T34	Eq-Operator 318 326	at least
T35	Eq-Unit 344 350	cycles
T36	Eq-Temporal-Unit 355 359	year
T37	Drug 370 398	anabolic androgenic steroids
T38	Drug-Name 370 398	anabolic androgenic steroids
T39	Study 444 449	study
T41	Observation 481 490	sedentary
T5	Observation-Name 481 490	sedentary
T42	Life-Stage-And-Gender 491 494	men
T43	Negation 495 502	without
T44	Observation 552 559	Smoking
T45	Observation-Name 552 559	Smoking
T46	Observation 566 585	Alcohol consumption
T47	Observation-Name 566 585	Alcohol consumption
T48	Drug 599 608	diuretics
T49	Drug-Name 599 608	diuretics
T50	Drug 616 644	antihypertensive medications
T51	Drug-Name 616 644	antihypertensive medications
T53	Modifier 661 667	kidney
T54	Modifier 651 656	Liver
A1	Eq-Temporal-Unit-Value T8 year
A2	Eq-Temporal-Unit-Value T9 week
A3	Eq-Temporal-Unit-Value T10 year
A4	Eq-Operator-Value T11 BETWEEN
A5	Eq-Operator-Value T12 BETWEEN
A6	Observation-Type-Value E3 social-habit
A7	Eq-Operator-Value T28 GTEQ
A8	Eq-Operator-Value T34 GTEQ
A9	Eq-Temporal-Unit-Value T36 year
A11	Life-Stage-And-Gender-Type T42 male
A12	Observation-Type-Value E20 social-habit
R1	If-Then Arg1:E11 Arg2:E12
R2	Or Arg1:E2 Arg2:E4
R3	During Arg1:E14 Arg2:E15
R4	Or Arg1:E21 Arg2:E22
R5	Or Arg1:E25 Arg2:E24
